期刊文献+

托拉塞米的利尿作用和安全性 被引量:16

Safety and tolerance of torasemide after a single and multiple oral administration
在线阅读 下载PDF
导出
摘要 目的观察健康受试者口服托拉塞米的利尿作用和安全性.方法1 9名健康男性受试者单次口服不同剂量托拉塞米5,10和20 mg(n=9)或连续7天每日口服托拉塞米10 mg(n=10).观察血压,尿量,24 h尿钾、钠、氯和血钾、钠、氯,心率,呼吸,心电图和心电监测,血常规,尿常规,血生化等指标.结果5,10,20mg 3组单次服药后24 h总尿量分别为2.24,2.60和3.17L(P<0.05),24 h尿钾、钠、氯的排泄随托拉塞米剂量增加而略增加(P>0.05).连续服药,首次药后的24h尿量及尿钾、钠、氯的量最多.单次和连续给药后血钾、钠、氯均未见下降,甘油三脂增加0.1~0.4 mmol·L-1(P<0.05).4例受试者出现药物不良反应.结论在5~20 mg,托拉塞米利尿作用随剂量增加而增加,国人对托拉塞米耐受性良好. Objective To evaluate the diuretic effect and safety of different andmultiple doses torasemide. Methods Nineteen normal male healthy subjects receivedsingle dose of either 5, 10 or 20 mg po with one week interval or single dose of 10 mgpo every morning for 7 days. Urine and volume of intake over 24 h period, bloodpressure, respiratory and heart rates, 24 h urine potassium/ sodium/chloride/creatinine/ calcium, complete blood count and chemistry, urinalysis andelertrocardiogram before and after the administration. Results Twenty-four h urinevolume after taking torasemide 5,10,20 mg were 2.14,2.60,3.17 L, respectively(P<0.05). There are a little increase with three doses about the urine potassium, sodium,chloride excretion over 24 h period. Urine volume and urine potassium, sodium,chloride excretion over 24 h period were highest after the first administration. Nodecrease in serum potassium, sodium, chloride after single dose and multiple doseswhile triglyceride increased 0.1~0.4 mmol.L-1. Four volunteers had adverse effects.Conclusion There was a clear dose-response relationship for diuretic activity. Goodtolerance and safety profile were observed in the given doses.
机构地区 中国医学科学院
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2004年第6期416-419,共4页 The Chinese Journal of Clinical Pharmacology
关键词 托拉塞米 利尿作用 安全性 torasemide diuretic effect safety
  • 相关文献

参考文献6

  • 1Knauf H, Mutschler E. Clinical pharmacokinetics and pharmacodynamics of torasemide[J]. Clin Pharmacokinet, 1998;34:1-24.
  • 2Blose JS, Adams KF, Patterson JH.Torsemide: a pyridine-sulfonylurea loop diuretics[J]. Ann Pharmacother, 1995;29:396-402.
  • 3Brater DC. Clinical pharmacology of loop diuretics[J]. Drugs, 1991;41:14-22.
  • 4Frieder HA, Buckley MMT. Torasemide-a review of its pharmacology,properties and therapeutic potential[J]. Drugs, 1991 ;41:81-103.
  • 5Goodfriend TL, Ball DL, Oelkers W, et al. V. Torasemide inhibits aldosterone secretion in vitro[J]. Life Sci, 1998;63:45-50
  • 6Fowler SF, Murray KM. Torsemide: A new loop diruetic[J]. Am J Health-Syst Pharm, 1995;52:1771 - 1780.

同被引文献114

引证文献16

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部